Most of radiotherapy treatment protocols require daily sessions, and these repeated trips to the radiotherapy center also can contribute to fatigue.

Most of radiotherapy treatment protocols require daily sessions, and these repeated trips to the radiotherapy center also can contribute to fatigue.

NovaGray develops and commercializes the first radiotherapy tolerance tests for patients treated for breast or prostate cancer.
Performed before the start of radiotherapy with a simple blood draw, the tests assess the patients’ individual radiosensitivity and determine their risk of developing late complications after radiotherapy.
Knowing a patient’s individual radiosensitivity is important information that can help: